Company Filing History:
Years Active: 2003
Title: The Innovations of Robert Mark
Introduction
Robert Mark is an accomplished inventor based in Lawrenceville, NJ (US). He has made significant contributions to the field of biotechnology, particularly through his work on polypeptides. His innovative approach has led to advancements that may impact the treatment of various disorders.
Latest Patents
Robert Mark holds a patent for a polypeptide known as Pablo, which interacts with Bcl-xL. This invention includes polypeptides that feature Bcl-xL binding domains, as well as novel binding domains of Pablo polypeptides. The nucleic acid molecules encoding these polypeptides are also part of his patent. These innovations are particularly useful in modulating apoptosis, especially in neural cells, and can aid in the treatment or prevention of disorders that benefit from the modulation of cell death.
Career Highlights
Robert Mark is associated with Wyeth, a prominent company in the pharmaceutical industry. His work there has allowed him to focus on groundbreaking research and development in the field of biotechnology. His contributions have been instrumental in advancing the understanding of apoptosis and its implications for health.
Collaborations
Some of Robert Mark's notable coworkers include Kathleen H Young and Andrew T Wood. Their collaborative efforts have likely contributed to the success of their projects and innovations.
Conclusion
Robert Mark's work exemplifies the impact of innovative thinking in biotechnology. His patent for the Pablo polypeptide represents a significant advancement in the modulation of cell death, with potential applications in treating various disorders.